LAPEBLI



Trademark Coverage

No Class Specified

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Owner
Timeline
  • Jun 17
    2013
    Abandonment Notice Mailed No Use Statement Filed
  • Jun 17
    2013
    Abandonment No Use Statement Filed
  • Apr 03
    2013
    TEAS Change Of Correspondence Received
  • Oct 24
    2012
    Notice Of Approval Of Extension Request Mailed
  • Oct 23
    2012
    Extension 1 Granted
  • Oct 18
    2012
    Extension 1 Filed
  • Oct 22
    2012
    Case Assigned To Intent To Use Paralegal
  • Oct 18
    2012
    TEAS Extension Received
  • May 15
    2012
    NOA Mailed SOU Required From Applicant
  • Mar 20
    2012
    Published For Opposition
  • Feb 29
    2012
    Notice Of Publication
  • Feb 16
    2012
    Law Office Publication Review Completed
  • Feb 16
    2012
    Assigned To LIE
  • Feb 01
    2012
    Approved For PUB Principal Register
  • Jan 18
    2012
    TEAS/Email Correspondence Entered
  • Jan 17
    2012
    Correspondence Received In Law Office
  • Jan 17
    2012
    TEAS Response To Office Action Received
  • Aug 02
    2011
    Non Final Action Mailed
  • Aug 02
    2011
    Non Final Action Written
  • Jul 29
    2011
    Assigned To Examiner
  • Apr 25
    2011
    New Application Office Supplied Data Entered In TRAM
  • Apr 25
    2011
    New Application Entered In TRAM